Clinical Trials Browser

Interventional × Melanoma × TPI-287 × Clear all

NCT01067066 2017-07-21

A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma

Phase 1 Terminated

Melanoma

NCT01340729 2013-04-05

Open-Label Study of TPI 287 for Patients With Metastatic Melanoma

Phase 1/2 Withdrawn

Melanoma, Recurrence, Disease Progression